ArticleCEN case reports2026
A case of giant renal angiomyolipoma and diabetic nephropathy with abnormalities in the genes TSC2 and HNF1B.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 57-year-old female patient with tuberous sclerosis and end-stage renal failure who had a history of diabetes mellitus and repeated renal hemorrhage after induction of dialysis underwent surgical nephrectomy. The renal tissue that caused the hemorrhage consisted of adipocytes, blood vessels, and smooth muscle cells, so angiomyolipoma was diagnosed. The cause of the hemorrhage was thought to be an abnormality in the vascular structure, i.e., disruption of the elastic plates that make up the vessel wall, and the presence of a hematoma in the same area. Diabetic nephropathy, which was observed in the atrophied native kidney, was presumed to be the cause of end-stage renal failure. Genetic analysis confirmed the presence of TSC2 mutation, which is linked to tuberous sclerosis, and HNF1B mutation, which is linked to diabetes. To our knowledge, this is the first report of a patient with HNF1B mutation who may have developed end-stage renal failure because of diabetic nephropathy and who also had histologic evidence of renal hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.